Different works in vivo have also observed the antioxidant effects of irisin via a rise in Nrf2 activity in a model of hepatic fibrosis (Shi et al. 2020) and a NASH model (Chen et al. 2019). This evidence concerns the gene FNDC5 and metabolic dysfunction-associated steatohepatitis.